Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness

Triple-negative breast cancer (TNBC) is cancer that tested as negative for estrogen receptors (ER), progesterone receptors (PR), and excess human epidermal growth factor receptor 2 (HER2) protein which accounts for 15%−20% of all breast cancer cases. TNBC is considered to be a poorer progn...

Full description

Bibliographic Details
Main Authors: Kha-Liang Lee, Yung-Che Kuo, Yuan-Soon Ho, Yen-Hua Huang
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/9/1334